Reanalyses of Randomized Clinical Trial Data

被引:127
作者
Ebrahim, Shanil [1 ,2 ,3 ,4 ]
Sohani, Zahra N. [2 ,5 ]
Montoya, Luis [6 ]
Agarwal, Arnav [7 ]
Thorlund, Kristian [1 ,2 ]
Mills, Edward J. [1 ,2 ,8 ]
Ioannidis, John P. A. [1 ,9 ,10 ,11 ]
机构
[1] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[3] McMaster Univ, Dept Anesthesia, Hamilton, ON L8S 4L8, Canada
[4] Hosp Sick Children, Dept Anaesthesia & Pain Med, Toronto, ON M5G 1X8, Canada
[5] McMaster Univ, Populat Genom Program, Hamilton, ON L8S 4L8, Canada
[6] Univ Hlth Network, Toronto, ON, Canada
[7] McMaster Univ, Fac Hlth Sci, Hamilton, ON L8S 4L8, Canada
[8] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada
[9] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[10] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA
[11] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2014年 / 312卷 / 10期
基金
加拿大健康研究院;
关键词
PERIPHERAL NEUROPATHY; EFFICACY CRITERIA; NATIONAL-SURVEY; ACUPUNCTURE; GENETICS; SCIENCE; DISEASE; MODEL;
D O I
10.1001/jama.2014.9646
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Reanalyses of randomized clinical trial (RCT) data may help the scientific community assess the validity of reported trial results. OBJECTIVES To identify published reanalyses of RCT data, to characterize methodological and other differences between the original trial and reanalysis, to evaluate the independence of authors performing the reanalyses, and to assess whether the reanalysis changed interpretations from the original article about the types or numbers of patients who should be treated. DESIGN We completed an electronic search of MEDLINE from inception to March 9, 2014, to identify all published studies that completed a reanalysis of individual patient data from previously published RCTs addressing the same hypothesis as the original RCT. Four data extractors independently screened articles and extracted data. MAIN OUTCOMES AND MEASURES Changes in direction and magnitude of treatment effect, statistical significance, and interpretation about the types or numbers of patients who should be treated. RESULTS We identified 37 eligible reanalyses in 36 published articles, 5 of which were performed by entirely independent authors (2 based on publicly available data and 2 on data that were provided on request; data availability was unclear for 1). Reanalyses differed most commonly in statistical or analytical approaches (n = 18) and in definitions or measurements of the outcome of interest (n = 12). Four reanalyses changed the direction and 2 changed the magnitude of treatment effect, whereas 4 led to changes in statistical significance of findings. Thirteen reanalyses (35%) led to interpretations different from that of the original article, 3 (8%) showing that different patients should be treated; 1 (3%), that fewer patients should be treated; and 9 (24%), that more patients should be treated. CONCLUSIONS AND RELEVANCE A small number of reanalyses of RCTs have been published to date. Only a few were conducted by entirely independent authors. Thirty-five percent of published reanalyses led to changes in findings that implied conclusions different from those of the original article about the types and number of patients who should be treated.
引用
收藏
页码:1024 / 1032
页数:9
相关论文
共 44 条
  • [11] REANALYSIS OF CLINICAL-TRIAL OF HOMEOPATHIC TREATMENT IN FIBROSITIS
    COLQUHOUN, D
    [J]. LANCET, 1990, 336 (8712) : 441 - 442
  • [12] The first placebo-controlled trial of a special butterbur root extract for the prevention of migraine: Reanalysis of efficacy criteria
    Diener, HC
    Rahlfs, VW
    Danesch, U
    [J]. EUROPEAN NEUROLOGY, 2004, 51 (02) : 89 - 97
  • [13] Doshi P, 2013, BMJ-BRIT MED J, V347, pf4251
  • [14] Raw data from clinical trials: within reach?
    Doshi, Peter
    Goodman, Steven N.
    Ioannidis, John P. A.
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2013, 34 (12) : 645 - 647
  • [15] The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience
    Doshi, Peter
    Jefferson, Tom
    Del Mar, Chris
    [J]. PLOS MEDICINE, 2012, 9 (04)
  • [16] Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma
    Gallo, Ciro
    De Maio, Ermelinda
    Di Maio, Massimo
    Signoriello, Giuseppe
    Daniele, Bruno
    Pignata, Sandro
    Annunziata, Annalisa
    Perrone, Francesco
    [J]. BMC CANCER, 2006, 6 (1)
  • [17] Holdren JP, PUBLIC ACCESS MEMORA
  • [18] HOLLY JMP, 1981, LANCET, V2, P1384
  • [19] HUFF JC, 1993, J MED VIROL, P93
  • [20] Improving Validation Practices in "Omics" Research
    Ioannidis, John P. A.
    Khoury, Muin J.
    [J]. SCIENCE, 2011, 334 (6060) : 1230 - 1232